IL17A and primary cutaneous T-cell non-Hodgkin lymphoma: High expression of IL-17F has been associated with significantly increased risk of disease progression independently of disease stage, sex, and age at the time of diagnosis and IL-17A with neutrophil infiltration in CTCL lesions [62, 70].